[{"Assets_0_Q3_USD":"65061000000.0","CIK":"818686","CommonStockSharesConverted_0_Q3_shares":"1125000000.0","Country":"Israel","EarningsPerShareBasic_1_Q3_USD":"-0.27","EarningsPerShareBasic_3_Q3_USD":"0.53","EarningsPerShareDiluted_1_Q3_USD":"-0.27","EarningsPerShareDiluted_3_Q3_USD":"0.53","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"11303387401.0","MinorityInterest_0_Q3_USD":"1404000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"2079000000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"-273000000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"541000000.0","NetIncomeLoss_1_Q3_USD":"-208000000.0","NetIncomeLoss_3_Q3_USD":"736000000.0","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","ProfitLoss_1_Q3_USD":"-197000000.0","ProfitLoss_3_Q3_USD":"771000000.0","RevenuesConverted_1_Q3_USD":"4529000000.0","RevenuesConverted_3_Q3_USD":"14295000000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":"19134000000.0","StockholdersEquity_0_Q3_USD":"17730000000.0","Ticker":"TEVA","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"1018000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"1020000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"1018000000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"1018000000.0","filed":"20181101","footnote":null,"form":"10-Q","fp":"Q3","fy":"2018.0","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","period":"20180930","qtrs":"0","uom":"USD"}]